In adults with cancer and VTE, DOACs were noninferior to LMWH for recurrent, nonfatal VTE at 6 mo.

Authors :: Bannow, Bethany T. Samuelson
Source :: Annals of Internal Medicine. Sep2023, Vol. 176 Issue 9, pJC104-JC104. 1p. 1 Chart.
Publication Year :: 2023
Abstract: Source Citation: Schrag D, Uno H, Rosovsky R, et al; CANVAS Investigators. Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial. JAMA. 2023;329:1924-1933. 37266947 Clinical Impact Ratings: GIM/FP/GP: Hospitalists: Oncology: Hematology: [ABSTRACT FROM AUTHOR]

Subjects :: *CANCER patients
*LOW-molecular-weight heparin
*ORAL medication
*DISEASE relapse
*CLINICAL trials

Full Text Access

Tools